论文部分内容阅读
目的分析单磷酸阿糖腺苷治疗带状疱疹的临床疗效。方法收集2010年3月至2011年10月在我院就诊的82例带状疱疹患者的临床资料随机分为观察组40例,对照组42例,在常规治疗的基础上对照组给予阿昔洛韦注射液静脉滴注,观察组给予注射用单磷酸阿糖腺苷静脉滴注,观察治疗效果。结果观察组在止泡、止痛、完全结痂及皮损痊愈时间方面优与对照组(P<0.05);对照组有效率为76.2%,观察组有效率为87.5%,两组比较差异有统计学意义(P<0.05),观察组无不良反应发生。结论单磷酸阿糖腺苷治疗带状疱疹安全有效。
Objective To analyze the clinical efficacy of adenosine monophosphate in the treatment of shingles. Methods The clinical data of 82 patients with herpes zoster treated in our hospital from March 2010 to October 2011 were randomly divided into observation group (n = 40) and control group (n = 42). On the basis of routine treatment, the control group was given acyclovir Wei injection of intravenous drip, the observation group given intravenous injection of adenosine monophosphate, to observe the therapeutic effect. Results The observation group was superior to the control group (P <0.05) in terms of anti-foaming, analgesic, complete scab and skin lesions recovery (P <0.05); the effective rate was 76.2% in the control group and 87.5% in the observation group, with statistical difference Significance (P <0.05), no adverse reactions in the observation group occurred. Conclusion Valasone monophosphate is safe and effective in the treatment of herpes zoster.